Corbus Pharmaceuticals Holdings (CRBP) Revenue Growth (1y) (2016 - 2021)
Corbus Pharmaceuticals Holdings (CRBP) Revenue Growth (1y) (2016 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 37.90% |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 64.24% |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 7.82% |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Corbus Pharmaceuticals Holdings | 135.08 Mn | 107.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -92.09% |
| Jun 30, 2021 | -52.31% |
| Mar 31, 2021 | -63.23% |
| Dec 31, 2020 | 106.02% |
| Sep 30, 2020 | -52.48% |
| Jun 30, 2020 | -99.02% |
| Mar 31, 2020 | -6.56% |
| Dec 31, 2019 | -14,313.95% |
| Sep 30, 2019 | 137.40% |
| Jun 30, 2019 | 3,308.27% |
| Mar 31, 2019 | 98.40% |
| Sep 30, 2018 | 36.99% |
| Jun 30, 2018 | 143.77% |
| Mar 31, 2018 | -26.53% |
| Sep 30, 2017 | 7.24% |
| Jun 30, 2017 | -11.70% |
| Mar 31, 2017 | 226.20% |
| Sep 30, 2016 | 335.64% |
| Jun 30, 2016 | 249.01% |